v3.26.1
Fair Value Measurements - Narrative (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2026
shares
Oct. 31, 2025
shares
Aug. 31, 2021
sale
Sep. 30, 2024
shares
Sep. 30, 2023
shares
Sep. 30, 2022
shares
Sep. 30, 2021
shares
Jun. 30, 2026
USD ($)
shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Purchase of marketable securities               $ 399,228,000 $ 907,199,000  
Maturities of marketable securities               714,000,000 $ 1,229,000,000  
Marketable securities               615,547,000   $ 919,602,000
Current contingent consideration               0   57,799,000
Contingent consideration               $ 170,550,000   $ 314,340,000
Probabilities of success                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Measurement input               0.28    
Motus                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Shares issued upon milestone achievements (in shares) | shares               4,610,838    
Shares issued in acquisition (in shares) | shares       182,182 177,203 171,427 2,889,367      
Motus | Level 3                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Current contingent consideration               $ 0    
Contingent consideration               170,600,000    
Motus | Development Milestone                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Shares issued in acquisition (in shares) | shares 364,397 364,566                
Motus | Development and regulatory milestones                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Proceeds of sale of priority review voucher obligated to pay to equity holders, percentage     50.00%              
Average sales prices of publicly disclosed priority review voucher sales obligated to pay equity holders, percentage     50.00%              
Number of publicly disclosed sales used to determine average sales price owed to equity holders | sale     3              
Current contingent consideration               $ 15,700,000    
AlgaeneX                    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                    
Shares issued upon milestone achievements (in shares) | shares               368,867